Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Polyrizon Ltd. (PLRZ : NSDQ)

• Company Description    Polyrizon Ltd. is a development stage biotech company specializing in the development of medical device hydrogels delivered in the form of nasal sprays. Polyrizon Ltd. is based in Raanana, Israel. Number of Employees: 6

• Price / Volume Information    Yesterday's Closing Price: $12.61 Daily Weekly Monthly 20 Day Moving Average: 9,528,654 shares Shares Outstanding: 1.04 (millions) Market Capitalization: $13.14 (millions) Beta: -4.51 52 Week High: $4,590.00 52 Week Low: $2.88 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 172.86% 169.26% 12 Week 102.12% 96.34% Year To Date -99.61% -99.68%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 5 HA-TIDHAR STREET - RAANANA,L3 4366507 ISR ph: 972-9374-0120 fax: - ir@polyrizon-biotech.com http://www.polyrizon-biotech.com

• General Corporate Information    Officers Tomer Izraeli - Chief Executive Officer Nir Ben Yosef - Chief Financial Officer Asaf Itzhaik - Director Oz Adler - Director Omer Srugo - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: M79549206 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: - Next Expected EPS Date: - Share - Related Items Shares Outstanding: 1.04 Most Recent Split Date: 11.00 (0.17:1) Beta: -4.51 Market Capitalization: $13.14 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: -

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.61 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 09/30/25 - - 06/30/25 - - 03/31/25 - - ROA 09/30/25 - - 06/30/25 - - 03/31/25 - - Current Ratio 09/30/25 - - 06/30/25 - 44.04 03/31/25 - - Quick Ratio 09/30/25 - - 06/30/25 - - 03/31/25 - - Operating Margin 09/30/25 - - 06/30/25 - - 03/31/25 - - Net Margin 09/30/25 - - 06/30/25 - - 03/31/25 - - Pre-Tax Margin 09/30/25 - - 06/30/25 - - 03/31/25 - - Book Value 09/30/25 - - 06/30/25 - 20.69 03/31/25 - - Inventory Turnover 09/30/25 - - 06/30/25 - - 03/31/25 - - Debt-to-Equity 09/30/25 - - 06/30/25 - - 03/31/25 - - Debt-to-Capital 09/30/25 - - 06/30/25 - - 03/31/25 - -

Powered by Zacks Investment Research ©